3[1]Gambino R. Editorial. C-reactive Protein undervalued underutilized[J]. Clin Chem, 1997,43(11):2017 ～ 2018. 被引量：1
4[2]Nel AE, Strachan AF, Welka HE, et al. Acute phase response in bronchiectasis and bronchus carcinoma [ J ]. Respiratory,1984,45(4) :406 ～ 409. 被引量：1
5[3]Der D, Wallace E, Sankaran R, et al. Value of C-reactive protein measurements in exacerbations of chronic obstructive pulmonary disease[J]. Respir Med, 1998,92(4):664 ～ 667. 被引量：1
6[4]Robin PS, Brian JL. C-reactive protein in simple community acquired pneumonia[J]. Chest,1995, 107:1028～ 1031. 被引量：1
7Ngeow YF,Suwanjutha S,Chantarojanasriri T,et al.An Asian study on the prevalence of atypical respiratory pathogens in community-acquired pneumonia.Int J Infect Dis,2005,9:144-153. 被引量：1
9Ostrosky-Zeichner L,Alexander BD,Kett DH,et al.Multicenter clinical evaluation of the (1→3) beta-D-glucan assay as an aid to diagnosis of fungal infections in humans.Clin Infect Dis,2005,41:654-659. 被引量：1
10Food and Drug Administration,HHS.Class Ⅱ Special Controls Guidance Document:serological assays for the detection of betaglucan.Fed Reqist,2004,69:56934-56936. 被引量：1
